Review
Aug 2026
CRISPR/Cas9-edited organoids as a platform for tailored research of colorectal cancer.
The potential of gene-edited organoids to discover the genetic and molecular mechanisms underlying colorectal cancer development, progression, and treatment resistance is explored.
Nikoleta Mojzesova, Petra Hladíková, Zuzana Kozovská et al.
· Neoplasma (Bratislava) · 0 citations